Amyloid-beta (Aβ) and tau protein are both involved in the pathogenesis of Alzheimer’s disease. Aβ produces synaptic deficits in wild-type mice that are not seen in Mapt−/− mice, suggesting that tau protein is required for these effects of Aβ. However, whether some synapses are more selectively affected and what factors may determine synaptic vulnerability to Aβ are poorly understood. Here we first observed that burst timing-dependent long-term potentiation (b-LTP) in hippocampal CA3-CA1 synapses, which requires GluN2B subunit-containing NMDA receptors (NMDARs), was inhibited by human Aβ1–42 (hAβ) in wild-type (WT) mice, but not in tau-knockout (Mapt−/−) mice. We then tested whether NMDAR currents were affected by hAβ; we found that hAβ red...
Summary: Soluble Aβ oligomers (oAβs) contribute importantly to synaptotoxicity in Alzheimer disease ...
NMDA receptors (NMDARs) play a crucial role for the acquisition of functional AMPARs during Hebbian ...
Abstract Background β Amyloid (Aβ)-mediated neuronal hyperactivity, a key feature of the early stage...
Amyloid beta (ABeta) and tau protein are both implicated in memory impairment in early Alzheimer’s d...
AbstractGluN2B subunit containing NMDARs (GluN2B-NMDARs) mediate pathophysiological effects of acute...
Onset and progression of Alzheimer’s disease (AD) pathophysiology differs between brain regions. The...
Abstract Amyloid beta (Aβ)-mediated synapse dysfunction and spine loss are considered to be early ev...
International audienceMany mouse models of Alzheimer's disease (AD) exhibit impairments in hippocamp...
Amyloid β (Aβ) and tau protein are both implicated in memory impairment, mild cognitive impairment (...
To elucidate whether a permanent reduction of the GIuN2B subunit affects the pathology of Alzheimer'...
In Alzheimer's disease (AD), dysregulation of intracellular Ca²⁺ signalling has been observed as an ...
Microtubule associated protein tau (MAPT) is involved in the pathogenesis of Alzheimer's disease and...
Synaptic loss is one of the major features of Alzheimer's disease (AD) and correlates with the degre...
Synaptic dysfunction during early stages of Alzheimer's disease (AD) is triggered by soluble amyloid...
Soluble oligomeric assemblies of amyloid β (Aβo) drive much of Alzheimer’s disease (AD) pathology. A...
Summary: Soluble Aβ oligomers (oAβs) contribute importantly to synaptotoxicity in Alzheimer disease ...
NMDA receptors (NMDARs) play a crucial role for the acquisition of functional AMPARs during Hebbian ...
Abstract Background β Amyloid (Aβ)-mediated neuronal hyperactivity, a key feature of the early stage...
Amyloid beta (ABeta) and tau protein are both implicated in memory impairment in early Alzheimer’s d...
AbstractGluN2B subunit containing NMDARs (GluN2B-NMDARs) mediate pathophysiological effects of acute...
Onset and progression of Alzheimer’s disease (AD) pathophysiology differs between brain regions. The...
Abstract Amyloid beta (Aβ)-mediated synapse dysfunction and spine loss are considered to be early ev...
International audienceMany mouse models of Alzheimer's disease (AD) exhibit impairments in hippocamp...
Amyloid β (Aβ) and tau protein are both implicated in memory impairment, mild cognitive impairment (...
To elucidate whether a permanent reduction of the GIuN2B subunit affects the pathology of Alzheimer'...
In Alzheimer's disease (AD), dysregulation of intracellular Ca²⁺ signalling has been observed as an ...
Microtubule associated protein tau (MAPT) is involved in the pathogenesis of Alzheimer's disease and...
Synaptic loss is one of the major features of Alzheimer's disease (AD) and correlates with the degre...
Synaptic dysfunction during early stages of Alzheimer's disease (AD) is triggered by soluble amyloid...
Soluble oligomeric assemblies of amyloid β (Aβo) drive much of Alzheimer’s disease (AD) pathology. A...
Summary: Soluble Aβ oligomers (oAβs) contribute importantly to synaptotoxicity in Alzheimer disease ...
NMDA receptors (NMDARs) play a crucial role for the acquisition of functional AMPARs during Hebbian ...
Abstract Background β Amyloid (Aβ)-mediated neuronal hyperactivity, a key feature of the early stage...